ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Ilumetri 200 mg/2 ml, Injektionslösung - 
66784003 Almirall AG
Ilumetri 200 mg/2 ml, Injektionslösung18.04.2019
  24.08.2023
Tildrakizumab (L04AC17) 
WHO-DDD 
07.15. 
07.15. 
B  
Yes 
IP 
2962.66Yes
    
10 %3238.50
7680667840039Biotechnologika
  
Composition
tildrakizumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 2 ml.
Packungsbestandteile
Injektionslösung 
  
 
Active AgentDose
Tildrakizumabum200mg / 2ml
BAG: Active AgentDose
Tildrakizumabum200 mg
 
Inactive agents
Histidini Hydrochloridum Monohydricum
Histidinum
Polysorbatum 80
Saccharum
 
Source
Data was imported : 08.11.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home